Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease.

CONCLUSION: Lifitegrast ophthalmic solution 5.0% appeared to be safe and well tolerated for the treatment of dry eye disease. Drop comfort with lifitegrast improved within 3 min of instillation.
PMID: 30112930 [PubMed - as supplied by publisher]

Source: European Journal of Ophthalmology - August 16, 2018 Category: Opthalmology Authors: Nichols KK, Donnenfeld ED, Karpecki PM, Hovanesian JA, Raychaudhuri A, Shojaei A, Zhang S Tags: Eur J Ophthalmol Source Type: research